3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
2
Sarcoma
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, B-Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
21
fludarabine
14
Rituximab
11
Immunotherapy, Adoptive
9
Specimen Handling
8
Vincristine
7
Prednisone
7
Magnetic Resonance Spectroscopy
7
Doxorubicin
7
Etoposide
6
Biopsy
6
glofitamab
5
zanubrutinib
4
polatuzumab vedotin
4
obinutuzumab
4
Lenalidomide
4
Bendamustine Hydrochloride
4
relmacabtagene autoleucel
3
loncastuximab tesirine
3
fludarabine phosphate
3
axicabtagene ciloleucel
3
Leukapheresis
3
Ifosfamide
3
Carboplatin
3
tafasitamab
2
etoposide phosphate
2
X-Rays
2
Nivolumab
2
Injections
2
Disulfides
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, B-Cell
×
Immunoconjugates
×
Clear all
NCT06796517
2025-01-28
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
Recruiting
72 enrolled